Simon Mucha

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Coagulopathy in COVID-19: Manifestations and management

Simon Mucha, Siddharth Dugar, Keith R. McCrae et al. · Cleveland Clinic Journal of Medicine · 2020 · 131 citations · Full text

Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle Arrest

Christian Kuntzen, Nilüfer Sonuc, Enrico N. De Toni et al. · Cancer Research · 2005 · 90 citations

Cd95-induced Apoptosis, Signal Transduction, Signaling Pathway +15

Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months

Andrew J. Admon, Theodore J. Iwashyna, Lee A. Kamphuis et al. · JAMA Network Open · 2023 · 59 citations · Full text